Cramer's Morning Take: Novo Nordisk 7/29/25
Squawk on the Street
00:00
Analyzing Drug Stock Dynamics and Market Competition
This chapter examines Novo Nordisk's recent struggles in the pharmaceutical market, including lowered forecasts and declining stock performance amid fierce competition. It also explores strategies for navigating these challenges, such as the potential for a price war to regain market position.
Transcript
Play full episode
